Bowman & Company’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660K | Sell |
8,440
-5,138
| -38% | -$402K | 0.29% | 71 |
|
|
2025
Q1 | $984K | Buy |
13,578
+1,091
| +9% | +$79.1K | 0.48% | 62 |
|
|
2024
Q4 | $924K | Buy |
12,487
+148
| +1% | +$11K | 0.48% | 63 |
|
|
2024
Q3 | $814K | Buy |
12,339
+1,412
| +13% | +$93.2K | 0.43% | 67 |
|
|
2024
Q2 | $1.01M | Buy |
10,927
+993
| +10% | +$91.7K | 0.58% | 49 |
|
|
2024
Q1 | $949K | Sell |
9,934
-322
| -3% | -$30.8K | 0.57% | 56 |
|
|
2023
Q4 | $782K | Buy |
10,256
+830
| +9% | +$63.3K | 0.54% | 56 |
|
|
2023
Q3 | $653K | Buy |
9,426
+1,753
| +23% | +$121K | 0.52% | 56 |
|
|
2023
Q2 | $724K | Buy |
7,673
+192
| +3% | +$18.1K | 0.55% | 51 |
|
|
2023
Q1 | $619K | Buy |
7,481
+2,936
| +65% | +$243K | 0.45% | 52 |
|
|
2022
Q4 | $339K | Sell |
4,545
-1,620
| -26% | -$121K | 0.26% | 68 |
|
|
2022
Q3 | $509K | Buy |
6,165
+240
| +4% | +$19.8K | 0.46% | 44 |
|
|
2022
Q2 | $563K | Buy |
5,925
+270
| +5% | +$25.7K | 0.49% | 42 |
|
|
2022
Q1 | $666K | Buy |
5,655
+91
| +2% | +$10.7K | 0.51% | 39 |
|
|
2021
Q4 | $722K | Buy |
+5,564
| New | +$722K | 0.56% | 29 |
|